These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11560969)

  • 1. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia.
    Arteaga CL
    J Clin Oncol; 2001 Sep; 19(18 Suppl):32S-40S. PubMed ID: 11560969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia.
    Arteaga CL
    Semin Oncol; 2002 Oct; 29(5 Suppl 14):3-9. PubMed ID: 12422308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational bases for the development of EGFR inhibitors for cancer treatment.
    Bianco R; Gelardi T; Damiano V; Ciardiello F; Tortora G
    Int J Biochem Cell Biol; 2007; 39(7-8):1416-31. PubMed ID: 17596994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer.
    Baselga J; Arteaga CL
    J Clin Oncol; 2005 Apr; 23(11):2445-59. PubMed ID: 15753456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer.
    Mendelsohn J; Baselga J
    J Clin Oncol; 2003 Jul; 21(14):2787-99. PubMed ID: 12860957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor (EGFR) signaling in cancer.
    Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
    Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
    Danielsen AJ; Maihle NJ
    Exp Cell Res; 2002 Apr; 275(1):9-16. PubMed ID: 11925101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB-targeted therapeutic approaches in human cancer.
    Arteaga CL
    Exp Cell Res; 2003 Mar; 284(1):122-30. PubMed ID: 12648471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy.
    Dougall WC; Qian X; Greene MI
    J Cell Biochem; 1993 Sep; 53(1):61-73. PubMed ID: 7901229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors.
    Rowinsky EK
    Annu Rev Med; 2004; 55():433-57. PubMed ID: 14746530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms for oncogenic activation of the epidermal growth factor receptor.
    Zandi R; Larsen AB; Andersen P; Stockhausen MT; Poulsen HS
    Cell Signal; 2007 Oct; 19(10):2013-23. PubMed ID: 17681753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors.
    Yang S; Qu S; Perez-Tores M; Sawai A; Rosen N; Solit DB; Arteaga CL
    Cancer Res; 2006 Jul; 66(14):6990-7. PubMed ID: 16849543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors.
    Ritter CA; Arteaga CL
    Semin Oncol; 2003 Feb; 30(1 Suppl 1):3-11. PubMed ID: 12644979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell transformation by the epidermal growth factor receptor and v-erbB.
    Hayman MJ; Enrietto PJ
    Cancer Cells; 1991 Aug; 3(8):302-7. PubMed ID: 1681843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
    Perera RM; Narita Y; Furnari FB; Gan HK; Murone C; Ahlkvist M; Luwor RB; Burgess AW; Stockert E; Jungbluth AA; Old LJ; Cavenee WK; Scott AM; Johns TG
    Clin Cancer Res; 2005 Sep; 11(17):6390-9. PubMed ID: 16144944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the epidermal growth factor receptor: a clinical reality.
    Baselga J
    J Clin Oncol; 2001 Sep; 19(18 Suppl):41S-44S. PubMed ID: 11560970
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
    Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
    Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.
    Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL
    Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB; Hota C; Wilson SM; Chambers AF
    Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
    Kapoor GS; Kapitonov D; O'Rourke DM
    Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.